Boehringer Ingelheim Venture Fund (BIVF) and High-Tech Gründerfonds have invested in a seed-funding round for Swiss biotech start-up Amal Therapeutics.
De Scorbiac was responsible for the Accenture Venture fund's activities in Europe
GP sells the Dutch employment agency to its CEO, ending its three-years ownership
Financing for the acquisition was provided by Santander Corporate and Commercial Banking
Sussex Place Ventures, Contour Ventures, Partnership Fund and Outrun Ventures also take part